A year in the life of the Cancer Moonshot
January 12 marked the year anniversary of President Obama’s announcement of the Cancer Moonshot initiative with the recommendation that his Vice President, Joseph Biden, becomes the head of the campaign.
Mr Biden, as someone who has personally felt the loss of cancer, willingly and enthusiastically accepted and took the reins as a focal point of his mission as Vice President. The Cancer Moonshot is a US nationwide initiative to bring about the cure to all types of cancer by the year 2020, similar to the previous Moonshot which landed man on the moon in 1969 after beginning the program in 1961.
The Cancer Moonshot is a US nationwide initiative to bring about the cure to all types of cancer by the year 2020, similar to the previous Moonshot which landed man on the moon in 1969 after beginning the program in 1961.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
Free
7 day trial access
- All the news that moves the needle in pharma and biotech
- Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
- Receive The Pharma Letter daily news bulletin, free forever.
Become a subscriber
£820
Or £77 per month
- Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
- Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
- Daily roundup of key events in pharma and biotech.
- Monthly in-depth briefings on Boardroom appointments and M&A news.
- Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
More on this story...
Today's issue
Company Spotlight
More Features in Pharmaceutical
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze